MYH6 and cardiomyopathy: According to a recent study demonstrated by Carroll et al., Myh6 sgRNA was delivered to cardiac-specific Cas9 transgenic mice to generate mouse cardiomyopathy and heart failure models by disrupting the Myh6 locus [128].